A major factor driving resistance to ADT is the ability of PCa cells to adapt to chronic low androgen conditions by upregulating AR activity through overexpression, gene amplification, and expression of transcriptionally active AR variants that lack the ligand-binding domain, Fig. 1A, 1B. This evidence concerns the gene AR and posterior cortical atrophy.